ABEO Shares Outstanding History



Below is a table of the ABEO shares outstanding history going back to 10/24/2014:

Date ABEO Shares Outstanding
10/24/201421304
11/14/201421464
12/19/2014532216
3/30/2015799552
5/14/2015970723
8/14/20151.31M
11/16/20151.31M
3/30/20161.31M
5/16/20161.31M
8/15/20161.34M
11/14/20161.60M
3/30/20171.61M
5/15/20171.61M
8/11/20171.61M
11/13/20171.87M
3/15/20181.89M
5/10/20181.89M
8/9/20181.92M
11/9/20181.92M
3/13/20191.92M
5/6/20191.97M
8/5/20191.97M
11/7/20192.05M
3/9/20203.34M
5/1/20203.35M
8/3/20203.39M
11/2/20203.94M
3/19/20213.95M
5/10/20213.96M
7/21/20214.05M
11/8/20214.08M
3/21/20225.90M
5/3/20225.88M
8/1/20225.95M
11/7/202217.18M
3/21/202317.71M
5/4/202318.78M
8/1/202324.76M
11/1/202324.77M
3/6/202427.36M

Also see: ABEO Market Cap History
ABEO YTD Return
ABEO Historical Shares Outstanding:
+114.62% CAGR
ABEO Historical Shares Outstanding: +114.62% CAGR

Mouse over chart for data details
10/24/2014 ...3/6/2024
Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosaan autologous, engineered cell therapy that is in development for recessive dystrophic epidermolysis bullosa. Co.'s development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat the unmet medical need ophthalmic diseases using the AIM™ capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs. We show 40 historical shares outstanding datapoints in our coverage of ABEO's shares outstanding history.

Understanding the changing numbers of ABEO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ABEO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ABEO by allowing them to research ABEO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ABEO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Abeona Therapeutics (ABEO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ABIO Shares Outstanding History
ABMD Shares Outstanding History
ABOS Shares Outstanding History
ABSI Shares Outstanding History
ABT Shares Outstanding History
ABVC Shares Outstanding History
ACAD Shares Outstanding History
ACCD Shares Outstanding History
ACER Shares Outstanding History
ACET Shares Outstanding History
More Healthcare companies »

 

ABEO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.